| Hans-Günter Meyer-Thompson | Verschiedenes
Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
Chaignot C, Zureik M, Rey G, Dray-Spira R, Coste J, Weill A.
Pharmacoepidemiol Drug Saf. 2018 Sep 25. doi: 10.1002/pds.4635.
Abstract